We’re excited to introduce Chai-2, a major breakthrough in molecular design. Chai-2 enables zero-shot antibody discovery in a 24-well plate, exceeding previous SOTA by >100x. Thread👇

Read the full article from @AndrewE_Dunn here:

There's no reason to believe the capabilities should plateau here. We look forward to pushing the boundaries of what’s possible at the intersection of biotech and AI.

This award reflects our team’s relentless focus on transforming biology from science into engineering.

This annual recognition celebrates the most ambitious and innovative biotech startups. In just 12 months since announcing our first funding round, we’ve raised $100M and launched Chai-2: our AI model that can design antibodies on the computer with double-digit success rates.

🚀 Chai Discovery has been named to the Endpoints News 11 list of the most promising biotech companies of 2025!

Hear directly from our founder Joshua Meier (@joshim5) and Mikael Dolsten on the exciting plans ahead. Welcome aboard, Mikael Dolsten! We're thrilled to have you join us.

@jacobeffron @Redpoint @joshim5 Listen to the full episode: Apple: https://t.co/oEEd8dJSbH Spotify: https://t.co/DeW07QP4P8 Youtube:

Find out more about the evolution of Chai-1 to Chai-2, the 200x leap in antibody design success rates, and what this means for drug discovery. Great AI podcast with @JacobEffron of @Redpoint, hosting our co-founder @joshim5 of @chaidiscovery.

Thank you @Nasdaq for the kind words and for lighting up Times Square! 💙 Excited to keep pushing the boundaries of molecular design with AI.

.@grgyap, Partner at @MenloVentures, shares how generative AI is profoundly changing drug discovery: "It offers you the potential to create new molecules that have never been thought of by humans before." "Now you have an opportunity to... make a drug by seeing inside the lock,

We @DCVC are excited to be backing @joshim5 and team on this quest. Power team 💪

🚀 Welcome to the portfolio, @chaidiscovery! Their Chai-2 model achieved a 100x improvement in antibody design. This is how you transform drug discovery. Thrilled to back this world-class team: @joshim5 @_jackdent @Mattmcpartlon1 @j_boitreaud For more on why we invested👉

Proud to announce @ChaiDiscovery has raised a $70M Series A from @MenloVentures & Anthology Fund (@AnthropicAI), @ThriveCapital, @OpenAI + others. 🧬 Chai is an applied AI lab building frontier tools for molecular design. This funding will power our new models, coming soon👇

🔬 Accelerating scientific breakthroughs with OCI. https://t.co/Rq7wtQIGIb @chaidiscovery leveraged OCI to support the advanced technology needs of its breakthrough AI model, Chai-2.

🎉 Congratulations to @ZhuoranQ for winning the Chen Institute and @ScienceMagazine AI Prize, recognizing his groundbreaking AI research in biochemistry. We’re honored to have him on the @chaidiscovery team!

Listen to today's @NoPriorsPod to hear why the @chaidiscovery team is bullish on biotech. Thank you to @saranormous for hosting @_jackdent and @joshim5.

We asked @joshim5 (Co-Founder @chaidiscovery) about the future of AI in biotechnology. "We have scientists working for years trying to enable a certain class of drug program." "If we can use machine learning to jump to potential (drug) solutions, that could really push up the

We’re grateful to many partners for making this possible: @OracleCloud for the massive compute that was required; @NVIDIAHealth for new GPU kernels and accelerating our sequence search; and @Sino_Biological and @AdaptyvBio for conducting many wet-lab experiments in the paper.

We believe that these results mark a transition from empirical discovery to deterministic molecular engineering. ✨Reach out at https://t.co/XjiXoIl9JA if you’d like access to Chai-2.

At the core of Chai-2’s success is its multimodal generative architecture, integrating all-atom structure prediction and generative modeling. This enables Chai-2 to create novel and epitope-specific binders. 🔬Whitepaper with more details: https://t.co/3hJXmNalP3